导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.62% | 958/1050 |
| 近一周 | -1.96% | 390/1104 |
| 近一月 | -2.41% | 260/1102 |
| 近一季 | 0.11% | 251/1092 |
| 近半年 | -15.59% | 903/1070 |
| 近一年 | -26.21% | 966/1018 |
| 近两年 | 0.62% | 884/926 |
| 近三年 | -21.07% | 779/834 |
| 成立以来 | 19.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.89% 904/1070 |
-16.49% 1041/1101 |
- - |
- - |
| 2025 | 5.58% 879/1065 |
9.47% 162/1014 |
4.32% 339/1038 |
0.64% 993/1050 |
-8.13% 834/1065 |
| 2024 | -4.57% 693/1011 |
-1.38% 394/960 |
-4.21% 586/983 |
9.32% 678/991 |
-7.59% 805/1011 |
| 2023 | -17.46% 612/952 |
1.36% 548/880 |
-10.02% 771/895 |
-6.92% 424/915 |
-2.77% 303/952 |
| 2022 | -35.55% 707/867 |
-25.77% 724/773 |
11.83% 197/806 |
-24.92% 798/845 |
3.41% 265/867 |
| 2021 | -1.88% 380/740 |
2.38% 83/580 |
4.58% 474/659 |
-14.55% 598/704 |
7.25% 139/740 |
| 2020 | 65.41% 162/554 |
13.24% 24/419 |
37.57% 41/466 |
7.73% 306/517 |
-1.44% 497/554 |
| 2019 | 63.95% 62/410 |
41.06% 48/1146 |
2.84% 119/1228 |
-0.24% 339/390 |
13.29% 87/410 |
| 2018 | - - |
- - |
3.63% 32/990 |
-4.26% 425/1000 |
-12.78% 704/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 中欧品质消费股票A VS. 东吴新产业精选股票A(580008) |